ORIC Pharmaceuticals, Inc.
ORIC
$12.06
-$0.16-1.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.98% | 5.73% | -13.74% | -20.03% | -28.16% |
| Total Depreciation and Amortization | 5.26% | 6.67% | 13.97% | 15.71% | 15.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 69.18% | 62.19% | 121.59% | 107.69% | 96.86% |
| Change in Net Operating Assets | -62.01% | -10.30% | -123.17% | -3.91% | 120.77% |
| Cash from Operations | 19.86% | 12.80% | -20.36% | -7.78% | -15.59% |
| Capital Expenditure | -3.65% | 91.63% | 81.08% | -77.52% | -284.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -59.86% | -570.45% | -512.97% | 137.04% | 103.97% |
| Cash from Investing | -60.18% | -579.13% | -520.84% | 136.29% | 103.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 160.87% | 88,147.62% | 16,409.31% | -99.80% | 26.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -44.05% | 100.00% |
| Cash from Financing | 160.87% | 86,765.87% | 16,358.58% | -99.99% | 26.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -126.35% | -367.70% | 506.34% | -130.54% | 631.74% |